142 related articles for article (PubMed ID: 12956910)
21. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.
Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK
Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544
[TBL] [Abstract][Full Text] [Related]
22. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
Gattu S; Maibach HI
Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous delivery of thalidomide and its N-alkyl analogs.
Goosen C; Laing TJ; du Plessis J; Goosen TC; Lu GW; Flynn GL
Pharm Res; 2002 Apr; 19(4):434-9. PubMed ID: 12033376
[TBL] [Abstract][Full Text] [Related]
24. Development and characterization of eucalyptol microemulsions for topic delivery of curcumin.
Liu CH; Chang FY
Chem Pharm Bull (Tokyo); 2011; 59(2):172-8. PubMed ID: 21297295
[TBL] [Abstract][Full Text] [Related]
25. Formulation and evaluation of curcumin gel for topical application.
Patel NA; Patel NJ; Patel RP
Pharm Dev Technol; 2009; 14(1):80-9. PubMed ID: 18821270
[TBL] [Abstract][Full Text] [Related]
26. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
Zhu X; Li F; Peng X; Zeng K
Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
[TBL] [Abstract][Full Text] [Related]
27. [Methods and models for percutaneous absorption studies of organophosphates].
Boudry I; Trescos Y; Vallet V; Cruz C; Lallement G
Pathol Biol (Paris); 2008 Jul; 56(5):292-9. PubMed ID: 18191343
[TBL] [Abstract][Full Text] [Related]
28. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
29. Effect of iontophoresis and switching iontophoresis on skin accumulation of ketoprofen.
Okuno M; Takahashi Y; Isowa K; Machida Y
Biol Pharm Bull; 2008 Mar; 31(3):487-92. PubMed ID: 18310915
[TBL] [Abstract][Full Text] [Related]
30. Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation.
Rhein L; Chaudhuri B; Jivani N; Fares H; Davis A
J Cosmet Sci; 2004; 55(1):65-80. PubMed ID: 15037921
[TBL] [Abstract][Full Text] [Related]
31. The effect of ion pairing on the skin permeation of amlodipine.
Jiang Y; Fang L; Niu X; Rui M; He Z
Pharmazie; 2008 May; 63(5):356-60. PubMed ID: 18557419
[TBL] [Abstract][Full Text] [Related]
32. Effect of O-acylmenthol and salt formation on the skin permeation of diclofenac acid.
Zhao L; Li Y; Fang L; Ren C; Xu Y; He Z
Drug Dev Ind Pharm; 2009 Jul; 35(7):814-26. PubMed ID: 19466898
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and Pharmacodynamics of Self-Assembled Cubic Liquid Crystalline Nanoparticle Gel After Transdermal Administration.
Zhu N; Wu XX; Tian Y; Zhu JX; Li JC
Med Sci Monit; 2018 Apr; 24():2330-2338. PubMed ID: 29666359
[TBL] [Abstract][Full Text] [Related]
34. Rheological characterization of a xanthan-galactomannan hydrogel loaded with lipophilic substances.
Koop HS; Da-lozzo EJ; de Freitas RA; Franco CR; Mitchell DA; Silveira JL
J Pharm Sci; 2012 Jul; 101(7):2457-67. PubMed ID: 22549766
[TBL] [Abstract][Full Text] [Related]
35. Biopharmaceutical profile of hydrogels containing pranoprofen-loaded PLGA nanoparticles for skin administration: In vitro, ex vivo and in vivo characterization.
Abrego G; Alvarado H; Souto EB; Guevara B; Bellowa LH; Garduño ML; Garcia ML; Calpena AC
Int J Pharm; 2016 Mar; 501(1-2):350-61. PubMed ID: 26844786
[TBL] [Abstract][Full Text] [Related]
36. Effects of glycerol on the in vitro percutaneous absorption of all-trans retinoic acid.
Singla R; Lee CH
Pharm Dev Technol; 2003 Aug; 8(3):229-37. PubMed ID: 12901689
[TBL] [Abstract][Full Text] [Related]
37. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
Prasad R; Koul V; Anand S; Khar RK
Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
[TBL] [Abstract][Full Text] [Related]
38. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib.
Senna TD; Mata Dos Santos HA; Kibwila DM; Leitao AC; Santos Pyrrho AD; de Padula M; Rosas EC; Padua TA; Lara MG; Riemma Pierre MB
Curr Drug Deliv; 2017; 14(7):992-1004. PubMed ID: 28124617
[TBL] [Abstract][Full Text] [Related]
39. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
[TBL] [Abstract][Full Text] [Related]
40. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
